Commentaries
Vol. 4 No. 2 (2025)
Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 July 2025
1167
Views
400
Downloads
Authors
Quoting Jake Elwood, after reading the review by May et al., “we’ve seen the light.” Indeed, the term “anticoagulation stewardship” can serve as a programmatic manifesto for every scientific society dealing with hemostasis and thrombosis. The expression “antimicrobial stewardship” has become widely used and integrated into healthcare service planning, so why not start thinking in terms of “anticoagulation stewardship”?.....
Downloads
Download data is not yet available.
Citations
1. May JE, Allen AL, Samuelson Bannow BT, et al. Safe and effective anticoagulation use: case studies in anticoagulation stewardship. J Thromb Haemost 2025;23:779-89. DOI: https://doi.org/10.1016/j.jtha.2024.11.024
2. Budnitz DS, Shehab N, Lovegrove MC, et al. US emergency department visits attributed to medication harms, 2017-2019. JAMA 2021;326:1299-309. DOI: https://doi.org/10.1001/jama.2021.13844
3. Burnett AE, Barnes GD. A call to action for anticoagulation stewardship. Res Pract Thromb Haemost 2022;6:e12757. DOI: https://doi.org/10.1002/rth2.12757
4. Anticoagulation Forum. Core Elements of Anticoagulation Stewardship Programs. Newton, Anticoagulation Forum; 2019.
5. National Quality Forum. Advancing Anticoagulation Stewardship: A Playbook. Washington, DC, National Quality Forum; 2022.
6. Barnes GD, Nallamothu BK, Sales AE, Froehlich JB. Reimagining anticoagulation clinics in the era of direct oral anticoagulants. Circ Cardiovasc Qual Outcomes 2016;9:182–5. DOI: https://doi.org/10.1161/CIRCOUTCOMES.115.002366
7. Sylvester KW, Chen A, Lewin A, et al. Optimization of DOAC management services in a centralized anticoagulation clinic. Res Pract Thromb Haemost 2022;6:e12696. DOI: https://doi.org/10.1002/rth2.12696
8. Samuelson Bannow B. Are outpatient anticoagulation management services the wave of the future (again)? Res Pract Thromb Haemost 2022;6:e12735. DOI: https://doi.org/10.1002/rth2.12735
9. Lee J, Lindsley J, Chasler J, et al. The impact of an antithrombotic stewardship program on heparin-induced thrombocytopenia management. J Pharm Pract 2023;36:1343-9. DOI: https://doi.org/10.1177/08971900221116185
10. Rudd K, Winans A, Triller D. Standardizing periprocedural anticoagulation management: a stewardship initiative. J Thromb Thrombolysis 2023;56:361-7. DOI: https://doi.org/10.1007/s11239-023-02854-2
11. Samuelson Bannow BT. Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective. J Thromb Haemost 2024;22:1819-25. DOI: https://doi.org/10.1016/j.jtha.2024.04.002
12. National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence: Clinical Guidelines. London, NICE; 2021.
13. Silvari V, Crowley E, Carey M, et al. Value of hospital anticoagulation stewardship programme: a systematic review. Thromb Update 2024;14:100158. DOI: https://doi.org/10.1016/j.tru.2023.100158
14. McLintock C, Pabinger I, Bauer KA, et al. International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis. J Thromb Haemost 2016;14:3-27. DOI: https://doi.org/10.1111/jth.13162
How to Cite
1.
Marietta M, Castaman G. Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”. Bleeding Thromb Vascul Biol [Internet]. 2025 Jul. 1 [cited 2025 Sep. 18];4(2). Available from: https://www.btvb.org/btvb/article/view/180
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Giovanni de Gaetano, Welcome to AICE and sincere wishes for peace for the new year 2024 , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 4 (2023)
- Augusto Di Castelnuovo, The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Carlamaria Zoja, Ariela Benigni, Giuseppe Remuzzi, Hemostasis and the kidney: an unforeseen initial opportunity to create a small research group that grew into an institute , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol, The new era of anticoagulation: factor XI and XII inhibitors , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Marco P. Donadini, Walter Ageno, Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 1 (2022)
- Cristina Santoro, Alessandro Casini, Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Paola Binetti, Thrombotic thrombocytopenic purpura: much done, but still a lot to do , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Paolo Prandoni, Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Giovanni de Gaetano, The importance of rigorous and engaging scientific communication , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga, Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
You may also start an advanced similarity search for this article.
